Eisai Ltd ADR (ESALY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESALY | ZTS | TAK | GRFS | NBIX |
| Company | Eisai Ltd ADR | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 62.5000 | 149.24 | 13.32 | 6.42 | 140.89 |
| High | 63.2900 | 151.74 | 13.33 | 6.44 | 144.70 |
| Low | 61.0000 | 148.75 | 13.21 | 6.29 | 138.01 |
| Last | 61.5100 | 150.88 | 13.23 | 6.39 | 138.97 |
| Change | -1.3250 | +1.32 | -0.15 | -0.09 | -1.12 |
| % Change | -2.11% | +0.88% | -1.12% | -1.39% | -0.80% |
| Volume | 331,801 | 3,640,400 | 924,500 | 963,500 | 927,900 |
| 20-Day Average Volume | 58,360 | 4,103,280 | 1,763,520 | 1,357,945 | 814,105 |
| Previous Close | 62.8350 | 149.56 | 13.38 | 6.48 | 140.09 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 64.1255 | 158.66 | 13.48 | 6.71 | 136.56 |
| 20-Day Raw Stochastic | 13.14% | 23.08% | 9.52% | 12.73% | 59.45% |
| 20-Day Relative Strength | 42.88% | 34.40% | 36.46% | 43.83% | 54.08% |
| Weighted Alpha | +14.94 | -20.05 | -20.66 | -2.33 | +39.67 |
| Today's Opinion | 40% Buy | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 64% Buy | 40% Sell | 72% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.08% since 01/23/23 | -0.70% since 04/17/24 | +0.61% since 04/17/24 | -2.89% since 04/17/24 | +4.31% since 04/17/24 |
| Low | 61.0000 on 01/30/23 | 144.80 on 04/22/24 | 13.12 on 04/18/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 64.7200 on 01/26/23 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -7.24% since 12/30/22 | -10.67% since 03/22/24 | -8.19% since 03/22/24 | +2.73% since 03/22/24 | -1.74% since 03/22/24 |
| Low | 60.4000 on 01/05/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 68.8500 on 01/06/23 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +1.67% since 10/28/22 | -18.91% since 01/24/24 | -9.88% since 01/24/24 | -16.58% since 01/24/24 | -0.81% since 01/24/24 |
| Low | 56.8800 on 11/09/22 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 73.9035 on 12/05/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +34.10% since 07/29/22 | -9.72% since 10/24/23 | -9.26% since 10/24/23 | -20.92% since 10/24/23 | +27.20% since 10/24/23 |
| Low | 39.1540 on 09/07/22 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 73.9035 on 12/05/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,638,976 | 68,402,608 | 42,345,264 | 4,455,389 | 13,939,936 |
| Shares Outstanding, K | 286,766 | 457,359 | 3,164,818 | 687,560 | 99,507 |
| Annual Sales | 6,730,410,000 | 8,544,000,000 | 29,803,340,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | 426,790,000 | 2,344,000,000 | 2,345,930,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 1,262,920,000 | 2,213,000,000 | 7,556,070,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | 25,840,000 | 525,000,000 | 718,900,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 0.31 | 0.85 | 0.53 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 11/07/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 02/02/23 | 05/02/24 | 05/09/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | 0.440 on 09/27/22 | 0.432 on 04/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | 09/27/22 | 04/18/24 | 09/28/23 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 72.22 | 27.36 | 6.85 | 0.00 | 55.23 |